Southeast Asset Advisors’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-95,181
| Closed | -$2.43M | – | 137 |
|
|
2022
Q3 | $2.43M | Sell |
95,181
-13,514
| -12% | -$345K | 0.41% | 37 |
|
|
2022
Q2 | $3.09M | Buy |
108,695
+1,269
| +1% | +$36.1K | 0.49% | 31 |
|
|
2022
Q1 | $3.79M | Buy |
107,426
+2,231
| +2% | +$78.7K | 0.5% | 33 |
|
|
2021
Q4 | $4.41M | Buy |
105,195
+41,706
| +66% | +$1.75M | 0.6% | 30 |
|
|
2021
Q3 | $3.12M | Buy |
63,489
+33,458
| +111% | +$1.64M | 0.51% | 43 |
|
|
2021
Q2 | $1.25M | Buy |
30,031
+10,626
| +55% | +$443K | 0.21% | 69 |
|
|
2021
Q1 | $692K | Buy |
+19,405
| New | +$692K | 0.12% | 82 |
|